Delayed response to anti-tuberculosis treatment in a patient on infliximab

This publication has 11 references indexed in Scilit:

• Unopposed Matrix Metalloproteinase-9 Expression in Human Tuberculous Granuloma and the Role of TNF-α-Dependent Monocyte Networks
  The Journal of Immunology, 2003
• Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance report
  Arthritis & Rheumatism, 2003
• Biologic therapies in the spondyloarthritis: new opportunities, new challenges
  Current Opinion in Rheumatology, 2003
• Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy
  Rheumatology, 2003
• Infectious complications of biologic treatments of rheumatoid arthritis
  Current Opinion in Rheumatology, 2003
• Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy
  Rheumatology, 2003
• Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management
  The Lancet Infectious Diseases, 2003
• Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases
  Current Opinion in Rheumatology, 2002
• Recommendations about the prevention and management of tuberculosis in patients taking infliximab
  Joint Bone Spine, 2002
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001